Recognizing the critical role health care providers play in curbing the opioid epidemic, the Department of Health has created education and tools to assist in navigating the complexities of the crisis. The Department offers free online and on-site education on topics including safe and effective opioid prescribing, strategies to identify substance use disorder, addressing substance use disorder, and referring patients to treatment. Participants are eligible to receive Continuing Medical Education (CME) and certain modules meet additional Pennsylvania licensing and relicensing requirements.
Educational modules are available as online continuing education courses on
TRAIN PA free of charge. You can find them by clicking on the link or searching for "PA-PDMP" in the course catalog.
On-Site Educational Sessions
Quality Insights is currently scheduling virtual and onsite education in all Pennsylvania counties. Please email PDMPEducation@qualityinsights.org to request more information or to schedule a session. Sessions will start after July 1, 2020. Eligible providers may receive CME credit based on meeting certain criteria.
If you are unable to attend an on-site session, you can take advantage of our online courses on TRAIN PA.
These activities have been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through partnership with the PDMP Office and the University of Pittsburgh School of Medicine. The University of Pittsburgh School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.
The University of Pittsburgh School of Medicine designates each module for a
maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Continuing Medical Education (CME) Requirements
All modules 1–7 can be used to meet the Medical and/or Osteopathic Boards' CME credit requirement of Patient Safety/Risk Management, and modules 3–7 can be used to meet the Act 124 of 2016 opioid education requirements. However, a provider cannot use the same module to meet both the Act 124 and Patient Safety/Risk Management requirements. See below for the specific requirements that each module meets:
Act 124 Pain Management||
Act 124 Prescribing Practices for Opioids||
Act 124 Identification of Addiction||
Patient Safety/Risk Management|
|Module 3||Modules 4 and 7||Modules 5 and 6||Modules 1, 2, 3, 4, 5, 6 and 7|
Evidence-Based Prescribing: Tools you can use to fight the opioid epidemic.
Module 1: Why Using the PDMP is Important for Achieving Optimal Health for Pennsylvania Citizens
Learn why the use of the PDMP is important to improving Pennsylvania's population health.
Module 2: How to Use the PDMP to Make Clinical Decisions
Learn how prescribers and pharmacists can integrate the PDMP into their clinical workflow and use the PDMP to make clinical decisions based on the most recent requirements and regulations.
Module 3: Using the PDMP to Optimize Pain Management
Learn how prescribers and pharmacists can use the PDMP to optimize a patient's pain management
Module 4: Opioid Prescribing Guide
Overview of opioid prescribing guidelines published by the Pennsylvania Department of Health for acute and chronic pain management in healthcare settings as well as information published by the Centers for Disease Control and Prevention for chronic and acute pain management in all medical practices.
Module 5: Referral to Treatment for Substance Use Disorder Related to Opioid Use
Learn how to determine whether a patient should be referred to substance use disorder treatment and how to conduct a "warm handoff" of that patient to specialty treatment.
Module 6: Approaches to Addressing Substance Use Disorder with Patients Identified by the PDMP
Learn how to incorporate Screening, Brief Intervention and Referral to Treatment (SBIRT) into clinical practice.
Module 7: Effective Opioid Tapering Practices
Overview of different opioid tapering strategies for prescribers who need to either taper a patient to a lower daily dosage or to discontinuation of opioid therapy.
Conflict of Interest Policy
No planners, members of the planning committee, content reviewers and/or anyone else in a position to control the content of this education activity have relevant financial relationships to disclose.
The Americans with Disabilities Act information
Participation by all individuals is encouraged. Advance notification of any special needs will help us provide better service. Please notify us of your needs at least two weeks in advance of the program by sending an email to
If you have any questions about this education initiative, please contact